If you have a question for our guest, host or DRG please submit it here.
An update from biopharma’s hotspot
Guest: Bob Coughlin, CEO, MassBio
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG,Part of Clarivate talks to Bob Coughlin, president and CEO of the Massachusetts Biotechnology Council. Bob provides insights from what is unarguably the world’s number one biopharma hotspot. Bob and Mike discuss how the industry has collaborated to counter the most immediate issues the COVID-19 pandemic has raised and how these could inform the future of biopharma. Bob also talks passionately about how partnering with patient groups is key to patient centricity to truly understand the real unmet patient need. Watch the full interview here. To view more videos in the Conversations in Healthcare series click here.
Listen to the audio
About our Guest
Bob Coughlin, CEO, MassBio
As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.